Medication adherence: Whose responsibility is it anyway?
Pharmaceutical manufacturers should feel empowered to lead the charge and improve medication adherence as a way to prevent downstream problems that would impact their organizations.
Advocating for a chief adherence officer in pharma
The pharmaceutical industry employs chief executive officers, chief financial officers, chief revenue officers and chief talent officers, but pharma has yet to employ a chief adherence officer, singularly tasked with going after pharma’s half-a-trillion-dollar revenue opportunity.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Digital health CEO: One challenge in selling to Big Pharma is “Who else is doing it?”
There’s getting patients to take their medications, and then there’s convincing big pharmaceutical companies that they should invest in innovative ways to try to get patients to take their medications. The latter, apparently, is more complicated than it sounds. That’s one thing I gleaned from a conversation with Tom Kottler, the CEO of a digital […]